Curanex (CURX) - מכפיל P/S עתידי

Curanex Pharma (CURX) - לוגו תאגידי

The projected P/S dynamics reflect current market expectations, where the 0.00 mark indicates the current state. Curanex Pharmaceuticals Inc (CURX) is developing GI therapy through partnerships with scientific centers. The asset's value growth depends on the success of new formulas and the licensing of developments. However, the speculative nature of the stock and the anticipation of early-stage tests are already priced in.

CURX Curanex Pharmaceuticals: שווי שוק להכנסות חזויות בטווח 27.08.2025 - 05.09.2025

Curanex - פילוחים אנליטיים ומדדי מפתח (CURX)

- מחיר שוק ויעדי מחיר של אנליסטים:
ניתוח מסכם של החברה:CURX (Curanex Pharmaceuticals Inc)
מוצרים מיוצרים של Curanex Pharma

Curanex Pharmaceuticals Inc (CURX) is optimizing costs by integrating quality control systems with external research organizations to minimize operational risks. Analyzing the forward P/S trend, the current value of 0.00 reflects the company's market valuation relative to expected annual sales; a decrease in this ratio indicates a discount to future revenues, allowing for an assessment of the business's fundamental value resilience amid inflationary pressures.